Off-Label Use of Upadacitinib in Crohn's Disease: A Case Series

被引:0
|
作者
Choudry, Nida [1 ]
Forster, Erin [1 ]
Kessler, Ethan [1 ]
机构
[1] Med Univ South Carolina, Charleston, SC USA
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 12S期
关键词
D O I
10.14309/01.ajg.0000995964.25499.a5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S55
引用
收藏
页码:S15 / S15
页数:1
相关论文
共 50 条
  • [1] Real World Experience With Off-Label Upadacitinib in Crohn's Disease at a Tertiary Care Center
    Braga Neto, Manuel Bonfim
    Schoenoff, Shayla
    Becker, Michelle
    Loftus, Edward V.
    Kane, Sunanda V.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S367 - S368
  • [2] Case Series: Upadacitinib as a Treatment for Crohn's Disease
    Thomas, Braden
    Thurston, Theresa
    Abraham, Bincy
    Glassner, Kerri
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 : S3 - S4
  • [3] Off-label use of dalbavancin in children: a case series
    Gamell, Anna
    Velasco-Arnaiz, Eneritz
    Lopez-Ramos, Maria Goretti
    Rios-Barnes, Maria
    Simo-Nebot, Silvia
    Fumado, Victoria
    Noguera-Julian, Antoni
    Fortuny, Claudia
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (08) : 2062 - 2067
  • [4] A CASE SERIES OF SUCCESSFUL OFF-LABEL USE OF FLIBANSERIN
    Trowbridge, P.
    Padhye, M.
    Rubin, R.
    JOURNAL OF SEXUAL MEDICINE, 2023, 20
  • [5] Off-label use of MESNA in Dupuytren's disease
    Di Martino, Alberto
    Costa, Vincenzo
    Martinelli, Nicolo
    Zagami, Maria Giovanna
    Denaro, Vincenzo
    MEDICAL HYPOTHESES, 2008, 70 (03) : 702 - 703
  • [6] Off-label use of JAK1 inhibitor upadacitinib in dermatology
    Zhang, Tian-Yi
    Zeng, Yue-Ping
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [7] Off-label use of rituximab in systemic rheumatic diseases: case series
    Araujo, Filipe
    Silva, Ines
    Sepriano, Alexandre
    Nero, Patricia
    Branco, Jaime C.
    ACTA REUMATOLOGICA PORTUGUESA, 2013, 38 (04): : 290 - 294
  • [8] Off-label use of tralokinumab in the treatment of bullous pemphigoid: a case series
    Maglie, Roberto
    Didona, Dario
    Solimani, Farzan
    Pipito, Carlo
    Baffa, Maria Efenesia
    Hertl, Michael
    Antiga, Emiliano
    BRITISH JOURNAL OF DERMATOLOGY, 2025,
  • [9] The curious case of off-label use
    Dresser, Rebecca
    HASTINGS CENTER REPORT, 2007, 37 (03) : 9 - 11
  • [10] Ustekinumab trough levels in children with Crohn's disease refractory to anti-tumor necrosis factor agents: a prospective case series of off-label use
    Bouhuys, Marleen
    Mian, Paola
    van Rheenen, Patrick F.
    FRONTIERS IN PHARMACOLOGY, 2023, 14